IRIDEX 

$1.1750
10
-$0.00-0.42% Today

Statistics

Day High
1.18
Day Low
1.174
52W High
1.65
52W Low
0.87
Volume
24,762
Avg. Volume
-
Mkt Cap
20.2M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.12
-0.08
-0.05
-0.01
Expected EPS
-0.01
Actual EPS
N/A

Financials

-18.31%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
97.34MRevenue
-17.82MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IRIX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Lumentum
LITE
Mkt Cap71.7B
Lumentum Holdings Inc. competes in the optical and laser technologies sector, similar to IRIDEX's focus on ophthalmic laser-based treatments.
Cooper Companies
COO
Mkt Cap13.24B
The Cooper Companies, Inc. offers medical devices for eye care, competing in the broader ophthalmology and optometry sectors alongside IRIDEX.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson, through its medical devices segment, offers products that compete in the eye health market, overlapping with IRIDEX's laser systems.
nVent Electric
NVT
Mkt Cap26.82B
nVent Electric Plc, while focused on electrical connection and protection, competes through its medical solutions, including technologies that can be applied in ophthalmology.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie Inc., through its acquisition of Allergan, competes in the eye care market, particularly in treatments that could be alternatives to IRIDEX's solutions.
Align Technology
ALGN
Mkt Cap12.52B
Align Technology, Inc. competes indirectly by offering medical devices in the broader healthcare sector, including technologies that can impact eye care.
Intuitive Surgical
ISRG
Mkt Cap145.58B
Intuitive Surgical, Inc. competes by offering robotic-assisted surgical systems, some of which can be applied in surgeries that overlap with treatments offered by IRIDEX.
Baxter International
BAX
Mkt Cap10.77B
Baxter International Inc. competes in the healthcare and medical devices sector, offering products that can be used in a wide range of treatments, including those related to eye health.
Boston Scientific
BSX
Mkt Cap69.72B
Boston Scientific Corporation competes in the medical devices market, offering products that, while not directly competing in ophthalmology, are part of the broader healthcare and medical equipment industry.

About

IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions. The Cyclo G6 system is specifically engineered for glaucoma treatment. For ailments like diabetic macular edema and other retinal pathologies, IRIDEX provides the IQ 532 and IQ 577 laser photocoagulation systems. Furthermore, the OcuLight series, encompassing models such as TX, SL, SLx, GL, and GLx, offers solutions for managing severe retinal issues like proliferative diabetic retinopathy, macular holes, and retinal tears or detachments. Beyond laser consoles, the company also manufactures specialized delivery instruments. These include the TxCell scanning laser delivery system, which empowers clinicians with multi-spot pattern scanning capabilities. A unique slit lamp adapter enables practitioners to integrate standard slit lamps into their diagnostic and therapeutic workflows. Additionally, a laser indirect ophthalmoscope is available for interventions targeting peripheral retinal disorders. IRIDEX's offerings extend to various probes. The MicroPulse P3 Probe, when coupled with the Cyclo G6 laser system, facilitates MicroPulse transscleral laser therapy. For managing uncontrolled glaucoma, the G-Probe is employed, while both the G-Probe and G-Probe Illuminate are utilized in procedures addressing refractory glaucoma. The EndoProbe product line supports a range of vitrectomy procedures. Their diverse client base spans ophthalmology professionals, academic and research hospitals, government healthcare facilities, specialized surgical centers, general hospitals, veterinary clinics, and private medical practices. Product distribution is handled via an internal and independent sales network across the United States, supplemented by independent distributors for its international markets. Originally incorporated in 1989 as IRIS Medical Instruments, Inc., the company adopted the name IRIDEX Corporation in November 1995. Its corporate headquarters are situated in Mountain View, California.
Show more...
CEO
Mr. Scott A. Shuda J.D.
Employees
93
Country
United States
ISIN
US4626841013

Listings

0 Comments

Share your thoughts

FAQ

What is IRIDEX stock price today?
The current price of IRIX is $1.18 USD — it has decreased by -0.42% in the past 24 hours. Watch IRIDEX stock price performance more closely on the chart.
What is IRIDEX stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange IRIDEX stocks are traded under the ticker IRIX.
Is IRIDEX stock price growing?
IRIX stock has risen by +4.91% compared to the previous week, the month change is a +16.34% rise, over the last year IRIDEX has showed a +19.29% increase.
What is IRIDEX market cap?
Today IRIDEX has the market capitalization of 20.2M
When is the next IRIDEX earnings date?
IRIDEX is going to release the next earnings report on August 06, 2026.
What were IRIDEX earnings last quarter?
IRIX earnings for the last quarter are -0.03 USD per share, whereas the estimation was -0.07 USD resulting in a +57.14% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is IRIDEX revenue for the last year?
IRIDEX revenue for the last year amounts to 97.34M USD.
What is IRIDEX net income for the last year?
IRIX net income for the last year is -17.82M USD.
How many employees does IRIDEX have?
As of June 16, 2026, the company has 93 employees.
In which sector is IRIDEX located?
IRIDEX operates in the Health & Wellness sector.
When did IRIDEX complete a stock split?
IRIDEX has not had any recent stock splits.
Where is IRIDEX headquartered?
IRIDEX is headquartered in Mountain View, United States.